About TECHLAB®

TECHLAB®, Inc. develops, manufactures, and distributes rapid non-invasive intestinal diagnostics in the areas of intestinal inflammation, antibiotic associated diarrhea and parasitology.

SSI Diagnostica continues strong growth journey by merging with Virginia-based TECHLAB

SSI Diagnostica Group (SSID), a global in-vitro diagnostics company backed by Adelis Equity Partners, has experienced significant growth in recent years based on its ability for new product innovation, expansion into international markets and strategic acquisitions. SSID’s latest transformational acquisition is the Virginia-based firm TechLab, Inc., a leading developer and manufacturer of rapid infectious disease … Continue reading

October 14, 2022 News

Characterization of Clostridioides difficile Strains from an Outbreak Using MALDI-TOF Mass Spectrometry

A recent study in Microorganisms reports the first case of a C. difficile tcdA+/tcdB outbreak strain. This C. difficile strain has a functional copy of the Toxin A gene (tcdA) that produces Toxin A but contains a mutation in the Toxin B gene (tcdB), limiting the ability to detect infections by molecular tests that target the tcdB region to detect infection. Click here to view the article. … Continue reading

August 11, 2022 News

The Microbiome and Recurrent Clostridioides difficile

Listen to The Microbiome and Recurrent Clostridioides difficile: Trust Your Gut (medscape.org), a CME accredited webinar led by Dr. Feuerstadt, Dr. Oneto, and Dr. Khanna, which discusses the burden of recurrent C. difficile infections (CDI) on patients & healthcare facilities. Patients with inflammatory bowel disease (IBD) who may be experiencing a flare should be tested for C. diff. A toxin-based … Continue reading

June 10, 2022 News

Testing for Clostridioides difficile and its disease

C. difficile causes 5-15% of hospital-acquired diarrheas and a growing number of community acquired diarrheas.  The infection can also be asymptomatic with carriage occurring frequently.  Each testing method has its strengths and weaknesses, but a multistep algorithm combines the sensitivity of a screen with the specificity of a toxin test to optimize patient care, minimize overdiagnosis,Continue reading

January 3, 2022 News

Managing the four-prong threat of CDI, antibiotics, the flu season and COVID-19

A recently published paper, Managing the four-prong threat of CDI, antibiotics, the flu seasons, and COVID -19, discusses the impact of COVID-19 on C. difficile infection rates.  Due to the pandemic,  health care facilities have adopted numerous mitigation procedures against COVID – 19 which have also reduced influenza rates and helped to lower the rate of hospital-acquired infections such as … Continue reading

August 16, 2021 News

The role of intestinal inflammation in C. difficile disease

In a recently published article written by Dr. David Lyerly and Jodie Lee, the role of intestinal inflammation is explored as it relates to C. difficile infection. The authors also note that inflammation correlates with disease severity. The complete article can be found here: https://www.mlo-online.com/diagnostics/article/21215179/the-role-of-intestinal-inflammation-in-clostridioides-difficile-diseas… Continue reading

March 26, 2021 News